Renewable oils manufacturer Solazyme (NASDAQ: SZYM ) got walloped after announcing a new commercialization strategy that will result in drastically reduced production volumes from facilities in Clinton, Iowa and Moema, Brazil and less revenue in 2015 and beyond than originally expected. The company's former commercialization strategy of selling massive volumes of commodity replacements relied on optimized, low-cost production and numerous customers. That stood in contrast to the strategy settled into by fellow industrial biotech Amyris (NASDAQ: AMRS ) at the end of 2012, which relied on producing low volumes of high value products, seeding important long-term markets, driving costs down with new microbial production strains, and adopting an efficient corporate cost structure.
Now, however, Solazyme is simply converging on the realizations of most other industrial biotech companies including Amyris, Pareto Biotechnologies (started with lean commercial strategy), REG Life Sciences, Metabolix, Deinove, Evolva, and others. While the market hasn't taken much interest in the long term value potential of Amyris' strategy, investors will want to educate themselves on the parallels, market realities, and timelines involved now that Solazyme is transitioning to a commercialization pathway nearly identical�to the rest of the field. Can Solazyme make a similar strategy work for its platform and two production facilities?
10 Best Cheapest Stocks To Buy Right Now: Vanguard Intermediate Term Bond ETF (BIV)
Vanguard Intermediate-Term Bond ETF (the Fund) seeks to track the performance of a market-weighted bond index with an intermediate-term, dollar-weighted average maturity. The Fund employs a passive management or indexing strategy designed to track the performance of the Barclays Capital U.S. 5-10 Year Government/Credit Bond Index (the Index). The Index includes all medium and larger issues of the United States Government, investment-grade corporate, and investment-grade international dollar-denominated bonds that have maturities between 5 and 10 years and are publicly issued. The Fund invests by sampling the Index, meaning that it holds a range of securities that, in the aggregate, approximate the full Index in terms of key risk factors and other characteristics. All of the Fund�� investments will be selected through the sampling process, and at least 80% of its assets will be invested in bonds held in the Index. The Fund�� investment advisor is The Vanguard Group, Inc. Advisors' Opinion:- [By GURUFOCUS]
In addition to individual stocks several funds pay a monthly dividend. Below is a sampling of these:
Monthly Bond Funds- iShares Barclays 1-3 Year Credit Bond (CSJ) | Yield: 1.29%
- Vanguard Short-Term Bond ETF (BSV) | Yield: 1.25%
- Vanguard Intermediate-Term Bond ETF (BIV) | Yield: 2.96%
- Vanguard Long-Term Bond ETF (BLV) | Yield: 4.42%
Top 10 Life Sciences Companies To Watch For 2014: Sands China Ltd (SCHYF)
Sands China Ltd. (Sands China) is an investment holding company. The Company, along with its subsidiaries, is engaged in the development and operation of integrated resorts in Macao, which contain not only gaming areas, but also meeting space, convention and exhibition halls, retail and dining areas and entertainment venues. The Company operates in five segments: The Venetian Macao, Sands Macao, The Plaza Macao, Sands Cotai Central and ferry and other operations. The Venetian Macao, the Plaza Macao and Other developments derive their revenue primarily from casino, hotel, food and beverage, mall, convention, retail and others sources. Ferry and other operations derive their revenue from the sale of ferry tickets for transportation between Hong Kong and Macau. As of December 31, 2011, its properties included 3,554 hotel rooms and suites, 74 restaurants, 1.2 million square feet of retail, 1.2 million square feet of meeting space, two permanent theaters, a 15,000-seat arena and the casino. Advisors' Opinion:- [By MARKETWATCH]
HONG KONG (MarketWatch) -- Hong Kong stocks rose early Wednesday, with the Hang Seng Index (HK:HSI) up 0.2% at 22,587.72. Hong Kong properties advanced, as the city's major developer Sun Hung Kai Properties Ltd. (HK:16) (SUHJY) rose 0.7%, after the company launched new luxury Riva project and saw the first batch of 64 flats sold out on the first day of sale. Sino Land Co. (HK:83) (SNLAF) rose 1.1%, Cheung Kong (Holdings) Ltd. gained 0.9%, and Henderson Land Development Co. (HK:12) (BACHY) edged up 0.2%. Chinese auto maker Dongfeng Motor Group Co. (HK:489) resumed trading and fell 0.9%, after the company said it signed an agreement with French joint-venture partner PSA Peugeot Citroen to invest 800 million euros ($1.1 billion) for a stake in the company. Most Casino stocks were lower, after reports said Macau planned to cut the duration of operators' licenses to 5 years. Shares of MGM China Holdings Ltd. (HK:2282) (MCHVF) declined 1.6%, SJM Holdings Ltd. (HK:880) lost 1%, and Sands China Ltds. (HK:1928) (SCHYF) dropped 0.8%. On the mainland, the Shanghai Composite Index (CN:SHCOMP) traded flat at 2,119.77.
Top 10 Life Sciences Companies To Watch For 2014: American Assets Trust Inc (AAT)
American Assets Trust, Inc. is a full-service vertically integrated and self-administered real estate investment trust (REIT). The Company owns, operates, acquires and develops retail, office, multi-family and mixed-use properties primarily in Southern California, Northern California, Oregon and Hawaii. The Company operates in four business segments: retail, office, multi-family and mixed-use. As of December 31, 2011, its portfolio consisted of 10 retail shopping centers; six office properties; a mixed-use property consisting of a 369-room all-suite hotel and a retail shopping center, and four multi-family properties. As of December 31, 2011, it owned land at five of its properties that the Company classified as held for development. On January 24, 2012, it acquired One Beach Street, consisting of approximately 97,000 rentable square feet in a renovated office building located along the Embarcadero in San Francisco�� North Waterfront District. On August 30, 2011, it sold Valencia Corporate Center.
On March 11, 2011, the Company acquired First & Main, an approximately 361,000 square foot, 16-story, office building located at 100 SW Main Street, in Portland, Oregon. On July 1, 2011, it acquired the Lloyd District Portfolio, consisting of approximately 610,000 rentable square feet on more than 16 acres located in the Lloyd District of Portland, Oregon. On September 20, 2011, it acquired the Solana Beach-Highway 101 property, consisting of approximately 1.7 acres located in Solana Beach, California. On December 14, 2011, it acquired an additional 0.2 acres adjacent to such location.
The Company is the sole general partner of American Assets Trust, L.P., a Maryland limited partnership (the Operating Partnership). The Company, as the sole general partner has control of its Operating Partnership and owned 67.8% of its Operating Partnership as of December 31, 2011. At December 31, 2011, its operating portfolio had approximately 705 leases with office and retail tenants, of which s! even expired on December 31, 2011 and 15 had not yet commenced. Its residential properties had approximately 753 leases with residential tenants at December 31, 2011, excluding Santa Fe Park RV Resort. The retail portion of its mixed-use property had approximately 64 leases with retailers.
Retail
The products for its retail segment primarily include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental. The Company�� retail properties include Carmel Country Plaza, South Bay Marketplace, Rancho Carmel Plaza, Lomas Santa Fe Plaza, Solana Beach Towne Centre, The Shops at Kalakaua, Waikele Center and Alamo Quarry Market. Its retail portfolio included 10 properties with a total of approximately three million rentable square feet available for lease as of December 31, 2011. As of December 31, 2011, these properties were 95% leased. During the year ended December 31, 2011, it signed 69 retail leases for 247,560 square feet. During 2011, the retail segment contributed 41.2%, of its total revenue.
Office
The products for its office segment primarily include rental of office space and other tenant services, including tenant reimbursements, parking and storage space rental. The Company�� office properties include Torrey Reserve, Solana Beach Corporate Centre, 160 King Street and The Landmark at One Market. Its office portfolio included six properties with a total of approximately 2.2 million rentable square feet available for lease as of December 31, 2011. As of December 31, 2011, these properties were 94.4% leased. During 2011, it signed 56 office leases for 233,213 square feet. During 2011, the office segment contributed 30.7% of its total revenue.
Multi-family
The products for its multi-family segment include rental of apartments and other tenant services. Its multi-family portfolio included three apartment properties, as well as an RV resort, with a total of 922 units! (includi! ng 122 RV spaces) available for lease as of December 31, 2011. As of December 31, 2011, these properties were 91.8% leased. Its multi-family leases, other than at its RV Resort, generally have lease terms ranging from 7 to 15 months, with a majority having 12-month lease terms. The Company�� multi-family properties include Loma Palisades, Imperial Beach Gardens, Mariner�� Point and Santa Fe Park RV Resort.
Mixed-Use Property
The products of its mixed-use segment include rental of retail space and other tenant services, including tenant reimbursements, parking and storage space rental and operation of a 369-room all-suite hotel. Waikiki Beach Walk Retail and Hotel is a mixed-use property. Its mixed-use property consists of 97,000 rentable square feet of retail space and a 369-room all-suite hotel. Revenue from the mixed-use property consists of revenue earned from retail leases, and revenue earned from the hotel, which consists of room revenue, food and beverage services, parking and other guest services. As of December 31, 2011, the retail portion of the property was 99.2% leased, and during 2011, the hotel had an average occupancy of 88.4%.
Advisors' Opinion:- [By Life Sciences Report]
AF: Kamada Ltd. (KMDA) is a relatively unknown Israeli company that is doing very well. It is listed on the Tel Aviv Stock Exchange and the NASDAQ. It has an intravenous form of a drug for alpha-1 antitrypsin (AAT) deficiency, which causes lung and liver disease, that is partnered with Baxter International Inc. (BAX).
Top 10 Life Sciences Companies To Watch For 2014: iShares MSCI EAFE Index Fund (EFA)
iShares MSCI EAFE Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the MSCI EAFE Index (the Index). The Index has been developed by Morgan Stanley Capital International, Inc. as an equity benchmark for international stock performance. The Index includes stocks from Europe, Australasia and the Far East. The Index is a capitalization-weighted index that aims to capture 85% of the (publicly available) total market capitalization.
The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. The Fund�� investment advisor is Barclays Global Fund Advisors.
Advisors' Opinion:- [By Dan Caplinger]
Many of Fidelity's�core offerings have extremely low bid-ask spreads of just a penny per share. But especially among funds where iShares replaced former offerings with similar new funds, bid-ask spreads are uncomfortably high in some cases. For instance, the iShares Core MSCI EAFE ETF has a much lower expense ratio of 0.14% than the 0.34% of the $41 billion iShares MSCI EAFE ETF (NYSEMKT: EFA ) , but the newly commission-free fund has an average bid-ask spread of 0.1%, equating to a typical spread of more than a nickel per share. You'll find a similar phenomenon comparing the iShares Core MSCI Emerging Markets ETF with the iShares MSCI Emerging Markets ETF (NYSEMKT: EEM ) , with lower costs for the former offsetting greater liquidity for the latter. The tiny iShares MSCI Emerging Markets Small-Cap ETF has the highest average bid-ask spread of the lot, at a whopping 1.5%. With a dozen funds sporting bid-ask spreads of more than a quarter-percent, you'll pay a high price for the lack of liquidity in some of the funds iShares and Fidelity have made available.
- [By anandjha89]
The markets fell by some 60% from 2008 into 2009. Our balanced income portfolio - 70% bonds to 30% stocks fell by less than 10% from its pre-crash peak. Our balanced portfolio - 60% stocks to 40% bonds fell by some 20%. Our balanced growth portfolio - 75% stocks to 25% bonds fell by some 35%. Our equity portfolio was not available at that time, but certainly the stock market correction was the great equalizer bringing the U.S. (SPY), international (EFA) and Canadian (EWC) markets down by some 60%. You can use those numbers as a general barometer of how asset mix affects volatility, and to match your own risk tolerance level to the asset mix. Are you 'comfortable' with a 60% drop, a 35% drop, a 20% drop or a 10% drop? Mix and match!
Top 10 Life Sciences Companies To Watch For 2014: Choice Hotels International Inc. (CHH)
Choice Hotels International, Inc., together with its subsidiaries, operates as a hotel franchisor worldwide. It franchises lodging properties under its proprietary brand names, including Comfort Inn, Comfort Suites, Quality, Clarion, Sleep Inn, Econo Lodge, Rodeway Inn, MainStay Suites, Suburban Extended Stay Hotel, Cambria Suites, and Ascend Collection brands. As of March 31, 2011, it operated 6,128 open hotels comprising 492,733 rooms, as well as 606 hotels consisting of 49,908 rooms under construction, awaiting conversion, or approved for development in 49 states, and the District of Columbia in the United States; and approximately 40 countries and other territories. The company was founded in 1981 and is based in Silver Spring, Maryland.
Advisors' Opinion:- [By John Udovich]
Small cap hotel stock La Quinta Holdings Inc (NYSE: LQ) just had its IPO to raise a lower than expected $650 million after being priced below its expected range, meaning its worth taking a closer look at the stock which�is focused on the�mid-priced hotel market along with the performance of potential benchmarks like hotel stocks Marriott International Inc (NASDAQ: MAR), Choice Hotels International Inc (NYSE: CHH) and Wyndham Worldwide Corporation (NYSE: WYN).
- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Choice Hotels International (NYSE: CHH ) , whose recent revenue and earnings are plotted below. - [By Sean Williams]
Don't make the wrong Choice
I predict that 2013 will be the return of the "staycation." In the depths of the recession, instead of taking expensive getaways, consumers chose simply to take time off work and stay home or locally. I think we have the perfect confluence of factors that could make life difficult for Choice Hotels International (NYSE: CHH ) , operator of Comfort Inn, Comfort Suites, and a multitude of other mid-price-point hotels. - [By Jeremy Bowman]
What: Shares of Choice Hotels (NYSE: CHH ) were getting picked last by investors today, falling 11% after cutting EPS guidance in its quarterly report.
Top 10 Life Sciences Companies To Watch For 2014: GenMark Diagnostics Inc.(GNMK)
GenMark Diagnostics, Inc. operates as a molecular diagnostics company primarily in the United States. It focuses on the development and commercialization of multiplexed molecular diagnostic testing systems for the detection and measurement of DNA and RNA targets used in the treatment of patients. The company?s products comprise eSensor XT-8 system, an automated molecular diagnostic system, which enable reference laboratories and hospitals to perform molecular diagnostic tests; and eSensor XT-8 Cartridge that utilizes a microfluidic system to accelerate target binding and enhance time to result. It also offers IVD tests, including eSensor cystic fibrosis genotyping test, eSensor thrombophilia risk test, and eSensor warfarin sensitivity test. The company?s other multiplexed molecular diagnostic tests pipeline under development comprise eSensor 2C19 test for the multiplexed detection and genotyping of various alleles of the cytochrome P450 (CYP450) 2C19 gene locus; eSensor respiratory viral panel, a nucleic acid multiplex test for the simultaneous detection and identification of multiple respiratory virus nucleic acids and mutations that confer resistance of Influenza A to the anti-viral drug Oseltamivir (Tamiflu); and eSensor KRAS/BRAF test for the multiplexed detection and genotyping of 12 mutations in codons 12 and 13 of KRAS and the V600E mutation in BRAF. GenMark Diagnostics, Inc. is headquartered in Carlsbad, California.
Advisors' Opinion:- [By Roberto Pedone]
GenMark Diagnostics (GNMK) is a molecular diagnostics company, engages in the development, manufacturing, marketing, sale, and support of instruments and molecular tests based on its proprietary eSensor detection technology in the U.S. This stock closed up 1.7% to $9.89 in Tuesday's trading session.
Tuesday's Range: $9.24-$9.95
52-Week Range: $6.38-$16.00
Thursday's Volume: 562,000
Three-Month Average Volume: 385,008From a technical perspective, GNMK bounced modestly higher here with above-average volume. This stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $8.75 on the downside and $10.71 on the upside. This bounce is starting to push GNMK within range of triggering a near-term breakout trade above the upper-end of its sideways trading chart pattern. That breakout will hit if GNMK manages to clear some near-term overhead resistance levels at $10.04 to $10.50 and then once it takes out more resistance at $10.71 with high volume.
Traders should now look for long-biased trades in GNMK as long as it's trending above Tuesday's low of $9.24 or around $9 and then once it sustains a move or close above those breakout levels with volume that hits near or above 385,008 shares. If that breakout triggers soon, then GNMK will set up to re-test or possibly take out its next major overhead resistance levels at $12 to $13.50.
Top 10 Life Sciences Companies To Watch For 2014: Endurance Specialty Holdings Ltd (ENH)
Endurance Specialty Holdings Ltd. underwrites specialty lines of personal and commercial property and casualty insurance and reinsurance worldwide. The company operates in two segments, Insurance and Reinsurance. The Insurance segment provides agriculture insurance covering traditional multi-peril crop insurance, crop hail, livestock risk protection, and other agriculture risk management products; and professional lines of insurance products, including directors� and officers� liability, errors and omissions, employment practices liability, environmental liability, and pension trust liability insurance. This segment also offers casualty and other specialty insurance products for third party liability; hospital medical professional liability; contract and commercial surety; and workers� compensation, as well as property insurance primarily for earthquake and flood coverage. The Reinsurance segment provides catastrophe reinsurance for catastrophic perils primarily for pro perty and workers� compensation business; property reinsurance for property insurance policies; and casualty reinsurance for third party liability exposures, such as automobile, professional, directors� and officers�, and umbrella liabilities, as well as for workers� compensation. This segment also offers aerospace reinsurance covering hull, aircraft liability, and aircraft products; marine reinsurance of bluewater and brownwater hull, and cargo risks; surety reinsurance for contract and commercial surety, and fidelity insurers; agriculture reinsurance for risks associated with the production of food and fiber; and personal accident and terrorism reinsurance products. The company distributes its products through independent agents, and insurance and reinsurance brokers. Endurance Specialty Holdings Ltd. was founded in 2001 and is based in Pembroke, Bermuda.
Advisors' Opinion:- [By cody56]
The fund in the third quarter letter discuss its best holdings which included medical device manufacturer Natus Medical Inc. (BABY), rail road service company Trinity Industries Inc. (TRN), resort operator Vail Resorts Ince (MTN), Correction Corp Of America (CXW), and Endurance Specialty Holdings Ltd. (ENH).
- [By Jake L'Ecuyer]
Equities Trading UP
Aspen Insurance Holdings (NYSE: AHL) shares shot up 11.33 percent to $43.83 after Endurance Specialty Holdings (NYSE: ENH) offered to buy Aspen Insurance for $47.50 per share in a cash and stock deal.
No comments:
Post a Comment